Construction of Phix174 gene E mediated lysis system for generation of Salmonella Enteritidis ghost, and its evaluation as a vaccine candidate for the.

Slides:



Advertisements
Similar presentations
January 22, 2007 Chapter 18 Chapter 19 Problems, problems, problems Coming up…….. - Objectives for 22, 23, 24 on or before Friday -Abstract (peer reviewed.
Advertisements

Essentials of Virology
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian virus Vaccine 2007 Huoying Shi, Xiu Fan Liu, Xiaorong Zhang,
Introduction to viruses
Section 18.1: Viruses Vocabulary: virus, host cell, bacteriophage, capsid, lytic cycle, lysogenic cycle, provirus, retrovirus, prions, viroids.
Vaccines Robert Beatty MCB150. Passive vs Active Immunity  Passive immunization transfer of antibodies  Vaccines are active immunizations (mimic natural.
Gene Expression Viruses Biotechnology
Viral & Prokaryotic Genetics “Simple” Model Systems.
1 Advanced Gene Technology. 2 Recombinant DNA Technology.
Unit 3 – Genetics Chapter 18~ Microbial Models: The Genetics of Viruses and Bacteria.
Vibrio Cholera Michelle Ross, Kristin Roman, Risa Siegel.
Bacterial Transformation RET Summer Overall Picture Bio-Rad pGLO Transformation Insertion of GFP gene into HB101 E. coli.
Types of vaccines 1 - First generation vaccines are whole-organism vaccines - either live and weakened, or killed forms. [1] Live, attenuated vaccines,
Sornkanok Vimolmangkang, Ph.D.
Cat1 Cat2Cat3Cat4 Potpourri.
The Sackler Faculty of Medicine
Regulation of Gene Expression
Viruses. Tobacco mosaic virus stunts the growth of tobacco plants and gives their leaves a mottled, mosaic coloration. Studied as early as 1883 by Adolf.
Viruses Viral Structure Growing (Cultivating) Bacteriophage Life Cycles Obligate Intracellular Parasites: Require living host cell in order to replicate.
Many methods are used to control pathogens.
Lecture #8Date _________ n Chapter 18~ Microbial Models: The Genetics of Viruses and Bacteria.
N Chapter 18~ Microbial Models: The Genetics of Viruses and Bacteria.
T4 bacteriophage infecting an E. coli cell 0.5  m.
Chapter 11 Phage strategies.
 Viruses (2) Biology 11 Mr. McCallum. What do viruses do?  Replicate, replicate, replicate!  Harmful as this leads to the death of the host cell 
Viruses. What are Viruses? Virus – particles of nucleic acid, protein, and in some cases lipids –Not alive –Do NOT exhibit characteristics of life –Can.
End Show Slide 1 of 21 Copyright Pearson Prentice Hall 13-3 Cell Transformation Recombinant DNA Host Cell DNA Target gene Modified Host Cell DNA.
Viral structure Nucleic acid in a protein coat (capsid) Nucleic acid in a protein coat (capsid) sometimes viral envelope (host cell membrane + viral proteins.
N Chapter 18~ Microbial Models: The Genetics of Viruses and Bacteria.
Chapter 18: Microbial Models: The Genetics of Viruses and Bacteria n Chapter 18: n Microbial Models: The Genetics of Viruses and Bacteria.
Chapters 15 – 17 Regulation of Gene Expression Development, Stem Cells, and Cancer Viruses.
Bacteria and Virus.
Infection and Disease Fungi Parasites Nosocomial infection Diagnosis of infectious disease.
Vaccines H.Sidra Yasin (BIOT 412). Learning objectives What are the Methods to produce the vaccines How we can modify the Vaccines What are the Routs.
Biotechnology Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Plasmid Isolation Prepared by Latifa Aljebali Office: Building 5, 3 rd floor, 5T250.
Microbial Models I: Genetics of Viruses and Bacteria 8 November, 2004 Text Chapter 18.
Chap 18 The Genetics of Viruses and Bacteria. Structure of Virus Approximately 20 nm in diameter Their genome can contain DNA or RNA. Enclosed by a.
Cat1 Cat2Cat3Cat4 Potpourri.
Making Vaccines. Effective Vaccines Have low levels of side effects or toxicity. Protect against exposure to natural, or wild forms of the pathogen. Should.
1 IMMUNE CORRELATES OF PROTECTION AGAINST INFLUENZA A VIRUSES IN SUPPORT OF PANDEMIC VACCINE DEVELOPMENT FDA/NIH/WHO Public Workshop, December 10-11, 2007.
Viruses and Bacteria Ch. 18. Viruses Parasite that requires a host cell in order to live They take the host cell hostage and use the cell to create the.
Chapter 27 Phage Strategies
MICROBIOLOGIA GENERALE
MICROBIOLOGIA GENERALE Viruses of prokaryotes. The main types of bacterial viruses.
Big Idea 3- Part C Gene Regulation. Regulation of metabolic pathways.
Unit Question: What is life and how does it maintain balance? Notes #8: The Immune System and Homeostasis Aim: What does your immune system do? Name:________________.
Viral vaccines  .
Virology Prof. Dr. Kareem Thamir Al-Kaabi. Objectives of the lecture The main objective of the present lecture is to understand the important chemical.
Sadia Sayed. The expression of the cloned gene in a selected host organism. It does not necessarily ensure that it will be successfully expressed. A high.
Use of Lactic acid Bacteria as Antigen Delivery Vehicle Kim, Tae-Woon Lab. of Food Biochemistry.
Reaves 31.2 – 31.4 Immunity.
Microbial Models: The Genetics of Viruses and Bacteria
Influenza Vaccines MedCh 401 Lecture 5 19May06 KL Vadheim Lecture 4.
Regulation of metabolic pathways
Section 31-4 “Immunity-Technology”
Immune System SC.912.L Explain the basic functions of the human immune system, including specific and nonspecific immune response, vaccines,
Chapter 19- Viruses.
Many methods are used to control pathogens.
Viruses.
Bacteriophage.
Many methods are used to control pathogens.
Many methods are used to control pathogens.
Keeley Choy Bacteriophage.
Many methods are used to control pathogens.
Many methods are used to control pathogens.
Week 15 Vocab Definitions
Chapter 18~ Microbial Models: The Genetics of Viruses and Bacteria
Many methods are used to control pathogens.
Presentation transcript:

Construction of Phix174 gene E mediated lysis system for generation of Salmonella Enteritidis ghost, and its evaluation as a vaccine candidate for the immunogenicity and protective efficacy against avian salmonellosis Chetan Vilas Jawale Post-doctoral Research Associate, College of Veterinary Medicine, Chonbuk National University, Jeonju, South Korea

Salmonella Enteritidis is the human illness-causing serovar most commonly associated with contaminated poultry meat and eggs. -Major disease complications: Gastroenteritis and diarrhoea-abdominal pain, vomiting, nausea, blood in stools. - Minor disease complications: Focal infection, Septicemia-Neurological complication, Osteomyelitis. - Morbidity and mortality is approximately 17% of all human salmonellosis cases. - In South Korea, prevalence rate of Salmonella Enteritidis is about 18.5% in food products. Despite the on-going implementation of targeted control and prevention measures, Salmonella Enteritidis is responsible for 93.8 million illnesses and 155,000 deaths worldwide each year. Bacterial food poisoning is a major world-wide health problem. Salmonellae remain among the leading sources of food-borne illness

Bacterial Ghost Technology  Genetically inactivating pathogenic Gram-negative bacteria by controlled expression of the cloned bacteriophage PhiX174 lysis gene E offers a promising new approach in non-live vaccine technology for protection against infectious diseases.  These are produced by controlled expression of the cloned bacteriophage PhiX174 gene E.  Gene E codes for a 91-amino-acid polypeptide that assembles and penetrates the inner and outer membranes of Gram-negative bacteria, leading to the formation of a transmembrane tunnel structure through the cell envelope, resulting in the loss of the cytoplasmic contents.  Bacterial ghosts (BG) are empty cell envelopes which possess intact bacterial surface structures and integrated antigen proteins.

The components of the ghost cassette E-lysis: Lysis gene E of the PhiX174 phage λP R : Rightward Lambda Promoter cI857: Thermolabile cI857 repressor of bacteriophage λ  The regulatory system is derived from the phage Lambda right promoter/operator system, and expression is controlled by the thermo-sensitive cI857 repressor, which enables the growth of bacteria at lower temperature, and E-mediated lysis at 42 o C

Representation of the lambda pL/pR promoters controlled by the cI857 repressor.

The ghost cassette is carried in the multi-copy plasmid (T-easy vector) Amp ® gene

Innoculation of S. Enteritidis ghost strain in LB broth Growth temperature 28 0 C Growth till mid-log phase Shift of culture to 42 0 C Induction and monitoring of lysis process for 48 hrs Harvesting of ghosts by centrifugation Work flow for production of ghost cells

Construction of Antibiotic resistance gene free Ghost Plasmid pJHL101

Balanced-Lethal Host-Vector System S. Enteritidis host with chromosomal Asd gene deletion Asd+ ghost plasmid + S. Enteritidis ghost Strain For overcoming the issue of antibiotic resistance gene marker, we used the auxotrophic asd gene based balanced-lethal host-vector system for carrying the E lysis cassette

The leaky expression of lysis gene E from λP R The leaky expression of lysis gene E induced the cell death at normal growth temperature of 28 o C

Ghost cassette with tight regulatory system for expression of PhiX174 gene E Lysis gene E is located between the sense λpR promoter with the cI857 regulator and antisense P araBAD promoter with the araC regulator.

In the presence of L-arabinose, the leaky transcription of lysis gene E at 28 o C from the sense λpR promoter was repressed by the simultaneous transcription event from P araBAD promoter through the anti-sense RNA mediated inhibition. A B I II

Shifting of optimally grown S. Enteritidis cultures at 42 0 C induced the lysis

Electron Microscopic characterization of SE ghost The single lysis pore appear either in the middle or polar regions of the cell, areas of the envelope actively involved in cell division

A- Non-immunized control B- Intramuscularly immunized C-Subcutaneously immunized D-Orally immunized Dosage of SE ghost for vaccination Parenteral - 1x 10 8 cells Oral- 1x cells

A- Non-immunized control B- Intramuscularly immunized Population of CD4 and CD8+ T cells after vaccination Cytokine profile of PBMC after in-vitro stimulation with SE antigen I II

Challenge study: Recovery of challenge strain from the internal organs of chickens Chickens from all the groups were challenged virulent SE at 4 weeks post-vaccination. Challenge dose: 1x10 9 CFU/bird via Oral route

Vaccination and challenge study in adult layer chickens Group A: Non-immunized challenge control Group B: Two time vaccination-challenge (Vaccination at 8 th and 16 th week of age) Group C: One time vaccination-challenge (Vaccination at 16 th week of age) Chickens from all the groups were challenged virulent SE at 23 rd week of age Challenge dose: 1x10 7 CFU/bird via intra-venous route

Effect of Vaccination on contamination of eggs with Salmonella Enteritidis

Conclusions 1)The stable system for production of bacterial ghosts was established 2)The production of bacterial ghosts is relatively simple approach for production of highly immunogenic genetically activated vaccines. 3) The S. Enteritidis ghosts are capable of inducing both the cell mediated and humoral immune responses after vaccination and are capable of protecting chickens against virulent S. Enteritidis chickens

* Prof. Lee John Hwa, DVM, Ph.D * Dr. Kim Sam Woong, Ph.D Acknowledgements